SOMATIX THERAPY CORP has a total of 36 patent applications. Its first patent ever was published in 1991. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and medical technology are MODEX THERAPEUTIQUES S A, HUANAN BIOLOGY MEDICINE RES INSTITUTE and SEMMA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 12 | |
#2 | Australia | 9 | |
#3 | Canada | 4 | |
#4 | EPO (European Patent Office) | 4 | |
#5 | Japan | 3 | |
#6 | United States | 3 | |
#7 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Medical technology | |
#4 | Foods and drinks | |
#5 | Macromolecular chemistry and polymers | |
#6 | Basic materials chemistry | |
#7 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Microorganisms | |
#3 | Object sterilising | |
#4 | Enzymes | |
#5 | Peptides | |
#6 | Therapeutic chemical compounds | |
#7 | Implantable devices | |
#8 | Special macromolecular compounds | |
#9 | Unspecified technologies | |
#10 | Preservation of human bodies |
# | Name | Total Patents |
---|---|---|
#1 | Cohen Lawrence K | 15 |
#2 | Mulligan Richard C | 14 |
#3 | Rafield Lori F | 14 |
#4 | Robbins Paul | 8 |
#5 | Birinyi Louis K | 7 |
#6 | Wilson James M | 7 |
#7 | Kuhn Robert | 6 |
#8 | Callow Allan D | 6 |
#9 | Ward Robert S | 6 |
#10 | Guild Brad | 6 |
Publication | Filing date | Title |
---|---|---|
AU5588298A | Adeno-associated viral vector-mediated delivery of dna to cells of the liver | |
AU1073797A | Joint expression of gtp cyclohydrolase and tyrosine hydroxylase | |
CA2220950A1 | Delivery vehicles comprising stable lipid/nucleic acid complexes | |
WO9609399A2 | Chimeric adenovirus for gene delivery | |
US6001350A | Genetic modification of endothelial cells | |
US5674722A | Genetic modification of endothelial cells | |
WO9322427A1 | Method of culturing viable cells and method of regulating the level of a compound in a body fluid | |
AU4114993A | Biocompatible, therapeutic, implantable device | |
US5411883A | Proliferated neuron progenitor cell product and process | |
WO9203046A1 | Improved cell cryopreservation method |